Cargando…
Benchmarking tocilizumab use for giant cell arteritis
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115674/ https://www.ncbi.nlm.nih.gov/pubmed/35601271 http://dx.doi.org/10.1093/rap/rkac037 |
_version_ | 1784709968823320576 |
---|---|
author | Conway, Richard Putman, Michael S Mackie, Sarah L |
author_facet | Conway, Richard Putman, Michael S Mackie, Sarah L |
author_sort | Conway, Richard |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9115674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91156742022-05-19 Benchmarking tocilizumab use for giant cell arteritis Conway, Richard Putman, Michael S Mackie, Sarah L Rheumatol Adv Pract Editorial Oxford University Press 2022-05-09 /pmc/articles/PMC9115674/ /pubmed/35601271 http://dx.doi.org/10.1093/rap/rkac037 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Conway, Richard Putman, Michael S Mackie, Sarah L Benchmarking tocilizumab use for giant cell arteritis |
title | Benchmarking tocilizumab use for giant cell arteritis |
title_full | Benchmarking tocilizumab use for giant cell arteritis |
title_fullStr | Benchmarking tocilizumab use for giant cell arteritis |
title_full_unstemmed | Benchmarking tocilizumab use for giant cell arteritis |
title_short | Benchmarking tocilizumab use for giant cell arteritis |
title_sort | benchmarking tocilizumab use for giant cell arteritis |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115674/ https://www.ncbi.nlm.nih.gov/pubmed/35601271 http://dx.doi.org/10.1093/rap/rkac037 |
work_keys_str_mv | AT conwayrichard benchmarkingtocilizumabuseforgiantcellarteritis AT putmanmichaels benchmarkingtocilizumabuseforgiantcellarteritis AT mackiesarahl benchmarkingtocilizumabuseforgiantcellarteritis |